Abstract. The distribution and expression of dystrophin and three of the dystrophin-associated glycoproteins (DAG), adystroglycan (156 kDa DAG), P-dystroglycan (43 kDa DAG) and adhalin (50 kDa DAG) in rat skeletal muscle were studied during a controlled cycle of degeneration and regeneration induced by the injection of a snake venom. Cryosections of muscle at various stages of degeneration and regeneration were labeled using monoclonal antibodies to the three glycoproteins and examined at fixed time points after venom injection. Adhalin and a-dystroglycan remained present at the sarcolemma throughout the entire cycle of degeneration and regeneration. P-Dystroglycan, on the other hand, was lost from the sarcolemma by 12 hours and reappeared 2 days after venom injection when new muscle fibers were being formed. Dystrophin was not lost from the sarcolemma until 24 hours after venom injection and did not reappear at the membrane until 4 days. It is suggested that dystrophin and the glycoprotein complex are synthesized separately, both temporally and spatially, and only become associated at the plasma membrane during the later stages of regeneration. The expression of P-dystroglycan in the regenerating muscle fibers was first seen at sites of newly forming plasma membrane that were closely associated with the old basal lamina tube. The basal lamina may therefore have a regulatory or modulatory role in the expression of the DAG.
INTRODUCTION
the rotary-shadowing method (9) , although slightly dif-
The degenerative myopathy, Duchenne muscular dystrophy (DMD), is the most common X-linked disorder in humans (1) and is associated with the absence of or a defect in dystrophin, the protein product of the gene located at position p21 on the short arm of the X-chromosome (2, 3). In previous studies, dystrophin has been shown to be localized to the plasma membrane of healthy muscle fibers (4) (5) (6) (7) (8) . Ultrastructural studies using goldlabeled monoclonal antibodies raised against defined epitopes of dystrophin showed that the dystrophin molecules label at intervals of approximately 165 nm along the internal face of the plasma membrane in both longitudinal and transverse orientation on sections of rat skeletal muscle. This labeling interval was in close agreement with measurements of the length of the putative dystrophin molecule isolated from chicken gizzard made using ferent from the measurements made from rabbit muscle (lo), and led to the suggestion that dystrophin molecules formed a regular lattice (1 1-14).
In 1989, Campbell's group showed that the linkage between dystrophin and the plasma membrane in skeletal muscle was mediated by a complex of glycoproteins (15) . This complex was shown to contain an intracellular 59 kDa protein (syntrophin); four transmembrane proteins of 50 kDa (adhalin), 43 kDa (P-dystroglycan), 35 kDa and 25 kDa; and an extracellular protein of 156 kDa (a-dystroglycan) (16) (17) (18) . Further work showed that the dystrophin molecule associated with syntrophin and P-dystroglycan (19) , while a-dystroglycan bound to laminin in the basal lamina (20) . It was later found that when dystrophin was absent in the muscles of patients with DMD, and of mice with X-linked muscular dystrophy (mdx), the dystrophin-associated glycoproteins (DAG) were also drastiially reduced or absent (16, (20) (21) (22) (23) In an earlier report, Vater et a1 (8) described a study of the expression and localization of dystrophin in degenerating and regenerating rat skeletal muscle. It was found that dystrophin was expressed and localized to the plasma membrane relatively late after the regenerative process had begun. We hypothesized that the DAG would b e expressed and localized earlier than dystrophin in the regenerating muscle fibers, and that the DAG may act as an anchor (or template) for the insertion of dystrophin into the membrane. T h e experiments described below were devised to explore this hypothesis and to aid our understanding of the relationship between dystrophin and its associated glycoproteins.
MATERIALS AND METHODS

Source of Tissue
Female Wistar rats weighing 90-120 g were anesthetized using a combination of 2.5% Halothane, 500 l/min N 2 0 and 300 l/min 0,. A single subcutaneous injection of 15 pg of whole venom (0.2 ml of 75 pg/ml in 0.9% w/v NaCl) from the Australian tiger snake, Notechis scutatus scutatus (Sigma, code V-0251), was made into the dorsolateral aspect of the left hind limb at the line of demarcation between the gastrocnemius and tibialis anterior muscles (32) . The injection was made thus so that the venom was introduced into the immediate vicinity of, rather than directly into, the underlying soleus muscle, thereby avoiding physical damage of the soleus muscle by the needle, and preventing necrosis incurred by such damage. Contralateral muscles served as controls. Both soleus muscles were removed at 1 hour (h) 
Preparation of Muscles for lmmunocytochemistry
The muscles were pinned to dental wax under slight tension and lightly fixed for 1 h in 2% w/v paraformaldehyde plus 0.001% w/v glutaraldehyde in 0.1 M phosphate buffer (PB, composition 0.02 M NaH,P0,.2H20; 0.08 M Na,HPO,; pH 7.35) at 4°C. This procedure allowed the preservation of antigenicity and, at the same time, the ultrastructural architecture of the muscle, which was to be studied ultimately both at the light and electron microscopic levels. After fixation, the muscles were washed in phosphate-buffered saline (PBS, composition 0.1 M PB; 0.15 M NaCI; pH 7.2), trimmed, and their mid-belly portions cut into small blocks of approximately 1.0 mm X 0.5 mm X 0.5 mm. The small tissue blocks were cryoprotected overnight in 2.3 M sucrose in 0.1 M PB at 4°C. The blocks were then mounted on aluminium rivets, plunge-frozen in liquid nitrogen, and stored in liquid nitrogen until use.
Longitudinal and transverse sections were cut using a Reichert FC4D cryoultramicrotome (knife temperature -95"C, block temperature -75°C) and transferred onto gelatin-coated slides on a drop of 2.3 M sucrose. The slides were then immersed in PBS, washed in 50 mM ammonium chloride in PBS, and excess moisture removed by gentle blotting. The sections were incubated for 1 h at room temperature in 10 The slides were washed twice in PBS, once in distilled water, dried around the sections, and mounted with Uvinert before examination using a Nikon Labophot fluorescence-optics microscope. Control sections were processed as described above, except that tissue culture medium containing 10% fetal calf serum (D,, tissue culture medium), normal rabbit serum, and an irrelevant IgG or IgM control of the same subclass as the primary mouse monoclonal antibody were used instead of primary antibody. All controls performed showed cryosections that were devoid of labeling by the secondary antibody.
Analysis of Western Blots
Small blocks of muscle (20-25 mg) were homogenized in 20 volumes of SDS treatment buffer, and 30 p,1 aliquots were used for polyacrylamide gel electrophoresis and Western blotting as described for dystrophin analysis (33) . The blots to be probed for P-dystroglycan were from 4-7% gradient gels, while the blots to be probed for a-dystroglycan and adhalin were from non-gradient 10% gels. In both cases the blots were blocked for 1 h at room temperature using a 10 mM Tris buffer containing 0.15 M NaCl and 0.05% v/v Tween 20 (TBST) plus 5% W/V skimmed dried milk powder. The blots were then incubated with primary antibody (anti-a-dystroglycan, neat; anti-P-dystroglycan, diluted 1:20; anti-adhalin, diluted 1 5 0 in TBST) for 1 h at room temperature. After washing, the blots were incubated with horseradish peroxidase-conjugated second antibody (DAKO P260), diluted 1:300 with TBST, for 1 h at room temperature. After washing, the blots were exposed to 0.05% w/v diaminobenzidine hydrochloride in PBS containing 0.025% vl v hydrogen peroxide for 5 minutes. After development of the bands, the blots were rinsed well, dried and mounted on filter paper.
Densitometry was used to obtain quantitative data from the Western blots. The blots and dried gels were scanned at an optical resolution of 400 d.p.i. using an Epson GT8000 flat bed scanner. The scanned images were stored as 256 greyscale TIFF files. The band images contained in the TIFF files were quantified using the Bioscan Optimas image analysis software package, modified for Western blots by K. Davison. The measurement technique employed assessed the total density contained within the boundaries of each band (volume relative optical density). Line graphs were drawn to present the densitometry data in a visual form. The relative optical density of each band was calculated for sets of both P-dystroglycan and dystrophin standards and venom-injected muscle samples, and graphs were plotted using a line of best fit from the values obtained. The dystrophin and P-dystroglycan standards were prepared by diluting homogenates of control muscle to produce a range of dilutions from 1.0 mg to 20.0 mg protein concentration. The standard graphs for both P-dystroglycan and dystrophin were each fitted by linear regression lines of y = 1 . 0 9~ -3.80 and y = 1 . 0 0~ -1.36, respectively, and which had correlation coefficients of r = 0.99 and r = 0.995, respectively (p > 0.001), indicating that densitometry was linear with the amount of protein loaded onto and transferred from the gels.
Terminology Used in the Text
The terminology applied to membrane systems surrounding muscle fibers is often confusing. In this work the following terminology is used:
Sarcolemma: The sarcolemma describes the structure including the outermost components of the cytoskeleton, the plasma membrane, the basal lamina, and the reticular network external to the basal lamina.
Plasma Membrane: The plasma membrane is the electrically excitable phospholipid membrane lying between the basal lamina and the cytoskeleton of the muscle fiber. The plasma membrane contains specific external, internal and transmembrane proteins, and these proteins determine the properties of the different parts of the membrane.
Basal Lamina: The basal lamina lies external to the plasma membrane of the muscle fiber. It is composed primarily of collagen type IV, but also contains collagen type V, laminin and fibronectin. It persists during degeneration of myofibers and is presumed to act as a mechanical scaffold during muscle repair and regeneration.
RESULTS
Pathology of Muscle Following Injection with Snake Venom
The toxic constituents of the venom of the Australian tiger snake, Notechis scutatus scutatus, damage skeletal muscle. The characteristics of the process are well known: individual muscle fibers began to exhibit hypercontraction and disruption of the plasma membrane at approximately 1-3 h, and by 6 h myofibrils and sarcomeres became disorganized and severely hypercontracted. There was extensive disruption of the plasma membrane, with perivascular infiltration of phagocytic cells. By 24 h the muscle fibers consisted of tubes of basal lamina containing clumps of degenerating myofibrillar debris and phagocytic cells. The microcirculation and the satellite cells were preserved. There was an early (12-24 h) activation of surviving satellite cells, and muscle fibers began to regenerate within the preserved basal lamina tubes by 2-3 d. The process of regeneration was virtually complete by 14-21 d. It was interesting to note that the intrafusal fibers of the muscle spindles tended to be spared from the effects of the venom. A detailed description of venom-induced damage to skeletal muscle can be found in Harris and Cullen (36) .
Control Muscle
Immunofluorescence studies of transverse sections of control soleus muscles labeled with monoclonal antibodies against a-and P-dystroglycan and adhalin showed that all three glycoproteins were localized at or near the plasma membrane of the muscle fibers in a manner not dissimilar to dystrophin (Fig. 1) . Labeling with the Pdystroglycan antibody was strong, distinct and continuous over the entire membrane (Fig. 1A) . Labeling with the adhalin antibody was occasionally slightly discontinuous (Fig. IB) . Labeling with the a-dystroglycan antibody was punctate, leading to distinct "beading" (Fig.  1C) . The respective patterns of labeling seen on longitudinal sections were similar to those seen on the transverse sections (not shown). Figure 1D demonstrates antidystrophin labeling at the plasma membrane, and Figure  1E shows cryosections of control muscle labeled with anti-laminin antibodies to illustrate the presence of the basal lamina.
Degenerating Muscle
Signs of skeletal muscle breakdown were observed as early as 1 h following venom assault. The muscle fibers displayed foci of hypercontraction and stretching, and there was an influx of phagocytic cells. Immunolabeling of cryosections of muscle removed 6 h after the inoculation of venom showed that P-dystroglycan was already lost from the plasma membrane of the most severely damaged myofibers, and by 12 h the majority of fiber profiles were P-dystroglycan-negative. A small number of fibers (approximately 30%) retained some weak and discontinuous labeling (Fig. 2A) . By 1 d post-injection, none of the fiber profiles were labeled for P-dystroglycan (Fig. 3A) . Adhalin and a-dystroglycan, on the other hand, were still present and labeled the sarcolemma strongly, despite the advanced stages of degeneration and regardless of whether the fibers were in a hypercontracted, stretched or collapsed state (Fig. 2B, C, 3B, C) . Interestingly, the intrafusal fibers of the spindles were positively labeled for P-dystroglycan, but negative for a-dystroglycan (Fig. 3A, C , open arrows) . Dystrophin was present in all fibers at 6 h and was absent from many fibers by 12 h (Fig. 2D) . By 24 h, the protein was essentially un- Fig. 9 . Graphs illustrating data from densitometric assays made on Western blots probed with monoclonal anti-P-dystroglycan and anti-dystrophin antibodies showing the amounts of these two proteins present in the venom-injected muscle samples at each stage throughout the cycle of degeneration (A) and regeneration (B). P-Dystroglycan showed a steep decline from the time of venom injection, such that 50% had been lost by 1 h, and was absent by 12 h. Re-expression of P-dystroglycan was apparent by 2 d and accumulated rapidly, such that 50% was reached by 3.5 d and 100% by 21 d. Dystrophin loss and accumulation followed a similar pattern to that seen with P-dystroglycan, but the time scale was different. Four h had passed before 50% loss was recorded, re-expression was not visible until 3 nation for the differences seen in the labeling patterns is that the rate of processing andlor turnover of these two glycoproteins may differ. Methods including labeling of "old" and "new" a-dystroglycan are required to assess accurately the actual time of expression of this glycoprotein during muscle regeneration.
In addition to the relationship between the glycoproteins of the complex, the interdependence of the dystrophin and glycoprotein components of the complex was of interest. It was noted that P-dystroglycan was inserted into the sarcolemma up to 48 h before the insertion of dystrophin. There are several possible explanations for this difference, and the most likely are examined in turn: (i) During normal development, dystrophin and the components of the glycoprotein complex may follow different routes to the plasma membrane. As a cytoskeletal protein, dystrophin will probably be synthesized on cytoplasmic ribosomes, whereas the glycoproteins will be synthesized on ribosomes of the rough endoplasmic reticulum (RER), before being transported through the Golgi apparatus of the regenerating muscle cells for sorting and glycosylation. The implication of this would be that dystrophin and P-dystroglycan would only associate on reaching the sarcolemma. (ii) If transcription of the P-dystroglycan and dystrophin genes was initiated at approximately the same time, a delay of 2 4 4 8 h would not be unexpected, since it takes at least 16 h to transcribe and translate the extremely long dystrophin gene, but far less for the P-dystroglycan gene (40) . Despite our lack of detailed knowledge on these points, the significant implication is that the DAG complex needs to be fully formed and established before the insertion of dystrophin into the plasmalemma, suggesting that the DAG act as a kind of "template" for the linkage with dystrophin, their positions possibly predetermined by signals originating in the basal lamina.
It was of considerable interest that the area of initial expression of the glycoproteins in regenerating myotubes was directly adjacent to the old basal lamina tube. The basal lamina, and in particular laminin, may, therefore, influence the expression and localization of these glycoproteins and dystrophin. It is also possible that a-dystroglycan, at least, may be involved in the attachment, spreading and growth of myoblasts along a substrate of laminin in the basal lamina (20) . It is likely that the basal lamina has an important modulatory, if not regulatory, role in the expression of the glycoproteins of the dystrophin-glycoprotein complex.
